99 results on '"Holmøy, Trygve"'
Search Results
2. Tuberculin responses after BCG vaccination predict amyotrophic lateral sclerosis risk
3. «At komme deres værdige og trængende Efterladte til Hjælp».
4. Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19.
5. Norsk helsevesen bør tilby stamcellebehandling mot multippel sklerose.
6. A Novel SPAST Variant Associated with Isolated Spastic Paraplegia.
7. CSF, Blood, and MRI Biomarkers in Skogholt's Disease—A Rare Neurodegenerative Disease in a Norwegian Kindred.
8. Serum sickness following rituximab therapy in multiple sclerosis
9. En kvinne i 60-årene som ikke lenger gjenkjente det hun så: Kvinnen i denne sykehistorien opplevde symptomer som rokket ved hennes visuelle erkjennelse av verden.
10. Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
11. Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a
12. Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study.
13. The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis.
14. En kvinne i 50-årene med økende gangvansker.
15. Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein
16. Vitamin D in multiple sclerosis: implications for assessment and treatment
17. Osteoporosis: an under-recognized risk for early-stage multiple sclerosis patients?
18. Amming og behandling av multippel sklerose.
19. En kvinne i 40-årene med ensidig tåkesyn og smerter ved øyebevegelse.
20. Disease-modifying therapy for multiple sclerosis.
21. Behandling som begrenser multippel sklerose.
22. Respiratorbehandling ved amyotrofisk lateral sklerose.
23. Den første norske doktorgraden om multippel sklerose.
24. Treatment of multiple sclerosis under the COVID-19 pandemic.
25. Behandling av multippel sklerose under covid-19-pandemien.
26. Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis.
27. CD4+ T Cells in the Blood of MS Patients Respond to Predicted Epitopes From B cell Receptors Found in Spinal Fluid.
28. En ung kvinne med krampeanfall, synsforstyrrelser og lammelser.
29. G1m1 predominance of intrathecal virus‐specific antibodies in multiple sclerosis.
30. Genetisk utredning ved amyotrofisk lateral sklerose.
31. In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis.
32. Selective intrathecal enrichment of G1m1-positive B cells in multiple sclerosis.
33. High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.
34. Listeria monocytogenes infection associated with alemtuzumab - - a case for better preventive strategies.
35. Prevalence and Characteristics Associated With Post–COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults.
36. Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study.
37. Familieplanlegging, graviditet og amming ved multippel sklerose.
38. Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.
39. High-throughput sequencing of immune repertoires in multiple sclerosis.
40. Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab.
41. A. H. Ali og medarbeidere svarer.
42. INGE PETTER KLEGGETVEIT STIAN HOVEN.
43. Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.
44. Miljøets betydning ved multippel sklerose.
45. Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis.
46. A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA).
47. Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis -- Association and Prediction.
48. Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation.
49. Bone Turnover and Metabolism in Patients with Early Multiple Sclerosis and Prevalent Bone Mass Deficit: A Population-Based Case-Control Study.
50. Identification of Human NK17/NK1 Cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.